CFDA announced that after the review
In May 16, 2017, CFDA announced that after the review, approval of the country's first "interventional biological heart valve products" registration. The announcement wrote, the product without the automatic positioning of the implantation site fast cardiLearn more > 2017-07-23
Professor Meng Xu's interpretation of domestic high-quality...
As an expert in cardiac surgery industry for 30 years, once the idea is really do not believe that domestic brands, but the company's health by understanding the first valve technology, he began to change the domestic brand is not only the inherent idea,Learn more > 2017-07-17